when does glp 1 patent expire Weight-loss drugs such as Ozempic were in the headlines a lot in 2025 – and protections for these drugs in some countries in 2026. In this edition of #PeriodicGraphics in @ Patents and regulatory exclusivities on
Description
Ozempic and Mounjaro are part of a class of drugs called GLP-1 receptor agonists, which act by mimicking hormones in the gut involved in insulin regulation and appetite.
Quality Verification: RP-HPLC validated
In order to better understand the full scope of the access challenges across the US for these critical medications, we launched the GLP-1 Supply Tracker so that anyone can be a part of advocating for continued access to the medications they need.
More fat burn
Log in to your member account to search for covered medications.
A combination medication like Janumet can be a better choice for people who aren't getting the diabetes management results they need from Metformin alone.
